New research links gene variant to greater weight loss with Wegovy

A new study suggests that individuals with a common gene variant, associated with a sweet tooth, may lose weight more effectively using the slimming drug semaglutide (Wegovy). This discovery could pave the way for personalized weight loss treatments.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

politikenDanish136d ago

Folk med en sød tand taber sig mere med Wegovy

Hvis man bærer på en hyppigt forekommende genvariant, som også er forbundet med en øget trang til søde sager, vil man tabe sig mere effektivt på slankemedicinen semaglutid, viser ny opsigtsvækkende undersøgelse. Det kan blive en vej til at skræddersy behandlingen til overvægtige personer.

Read full article →

New research links gene variant to greater weight loss with Wegovy

Sources

Folk med en sød tand taber sig mere med Wegovy

Related Stories

Lionel Richie Hospitalized in Intensive Care After Concert Illness

Lionel Richie Hospitalized in ICU Following St. Louis Concert

Novartis Pauses Autoimmune Cell Therapy Trials Following Patient Deaths

Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue